Medicare Enrolled

Dr. Charles Connor, M.D.

Medical Oncology · Plano, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
3705 W 15TH ST, Plano, TX 75075
9728673577
In practice since 2006 (19 years)
NPI: 1538102934 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Connor from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Connor? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Connor

Dr. Charles Connor is a medical oncology specialist in Plano, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Connor performed 59,012 Medicare services across 2,612 unique beneficiaries.

Between the years covered by Open Payments, Dr. Connor received a total of $1,694 from 24 pharmaceutical and/or device companies across 47 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Connor is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 17% volume in TX $1,694 industry payments

Medicare Practice Summary

Medicare Utilization ↗
59,012
Medicare services
Top 17% in TX for medical oncology
2,612
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,106 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron sucrose injection (Venofer) 23,400 $0 $2
Darbepoetin injection (Aranesp) for anemia 12,750 $2 $20
Pembrolizumab injection (Keytruda) 4,400 $43 $136
Contrast dye for imaging (iodine-based) 4,001 $0 $3
Immune globulin infusion (Octagam) 2,590 $34 $233
Paclitaxel chemotherapy injection 2,268 $0 $8
Denosumab injection (Prolia/Xgeva) 1,620 $18 $65
Dexamethasone injection (steroid) 1,414 $0 $1
Injection, granisetron hydrochloride, 100 mcg 840 $0 $24
Blood draw (venipuncture) 689 $8 $20
Complete blood count (CBC) with differential 670 $8 $36
Comprehensive metabolic blood panel 542 $10 $64
Injection of additional new drug or substance into vein 395 $12 $108
Office visit, established patient (20-29 min) 388 $62 $250
Anti-nausea injection (Aloxi/palonosetron) 270 $1 $114
Administration of chemotherapy into vein, 1 hour or less 220 $97 $707
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 189 $47 $313
Ferritin level test (iron stores) 178 $13 $60
Drug injection, under skin or into muscle 139 $10 $96
Injection, fluorouracil, 500 mg 115 $2 $13
Iron level test 114 $6 $27
Iron binding capacity test 114 $9 $35
Office visit, established patient (30-39 min) 103 $89 $368
Injection, zoledronic acid, 1 mg 101 $7 $431
Injection, diphenhydramine hcl, up to 50 mg 98 $1 $7
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 92 $54 $211
Injection, carboplatin, 50 mg 92 $2 $300
Infusion, normal saline solution , 1000 cc 79 $2 $19
Lactate dehydrogenase (enzyme) level 78 $6 $31
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour 76 $16 $100
Reticulated (young) platelet measurement 75 $35 $143
Unclassified drugs 74 $1 $8
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 71 $22 $157
Administration of chemotherapy into vein, each additional hour 66 $21 $161
Administration of additional new drug or substance into vein, 1 hour or less 62 $49 $344
Infusion into a vein for hydration, each additional hour 50 $10 $75
Microscopic examination for white blood cells with manual cell count 49 $4 $22
Complete blood count (CBC), automated 49 $6 $34
Ct scan of chest with contrast 44 $46 $821
New patient office visit (30-44 min) 40 $78 $372
CT scan of abdomen and pelvis with contrast 39 $168 $1,067
Drawing of blood for a medical problem 35 $63 $264
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev 32 $177 $700
CT scan of chest, without contrast 25 $35 $686
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session 25 $272 $2,762
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion 24 $15 $94
Red blood count, automated test 21 $4 $23
Infusion into a vein for hydration, 31-60 minutes 21 $25 $256
Hospital follow-up visit, moderate complexity 21 $61 $247
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev 21 $178 $700
Ct scan of abdomen and pelvis without contrast 20 $71 $560
Office visit, established patient (10-19 min) 20 $33 $150
Injection, fosnetupitant 235 mg and palonosetron 0.25 mg 20 $339 $1,722
Injection of drug or substance into vein 19 $28 $247
Irrigation of implanted venous access drug delivery device 18 $17 $114
Administration of additional new drug or substance into vein using push technique 17 $42 $289
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 16 $91 $657
Nuclear medicine study from skull base to mid-thigh with ct scan 13 $1,115 $4,802
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.3% high complexity
89.0% medium
5.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,694
Total received (2018-2024)
Avg $282/year across 6 years
Bottom 35% in TX for medical oncology
24
Companies
47
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,574 (92.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$120 (7.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$323
2023
$312
2022
$942
2021
$38
2019
$15
2018
$64

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$556
Novartis Pharmaceuticals Corporation
$230
Blueprint Medicines Corporation
$135
Kite Pharma, Inc.
$121
Pharmacyclics LLC, An AbbVie Company
$84
AbbVie, Inc.
$64
ABBVIE INC.
$61
Merck Sharp & Dohme LLC
$58
Integra LifeSciences Corporation
$42
Acrotech Biopharma LLC
$38
Takeda Pharmaceuticals U.S.A., Inc.
$33
E.R. Squibb & Sons, L.L.C.
$29
PFIZER INC.
$28
AbbVie Inc.
$25
Janssen Biotech, Inc.
$24
Apellis Pharmaceuticals, Inc.
$23
Amgen Inc.
$23
GE HealthCare
$21
Iovance Biotherapeutics, Inc.
$20
Pharmacyclics LLC, an AbbVie Company
$20
GENZYME CORPORATION
$16
Rigel Pharmaceuticals, Inc.
$16
Exelixis Inc.
$16
Gilead Sciences, Inc.
$12
Top 3 companies account for 54.3% of total payments
Associated products mentioned in payments ›
AYVAKIT · Amtagvi · BELEODAQ · CODMAN CERTAS · Cabometyx · DARZALEX · ENJAYMO · EPKINLY · Empaveli · Fabhalta · IBRANCE · ICLUSIG · IMBRUVICA · KEYTRUDA · KISQALI · MEKINIST · Nplate · OPDIVO · Pomalyst · Rezlidhia · VENCLEXTA · Venclexta · Yescarta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $3 per 100 Medicare services performed
Looking for a medical oncology specialist in Plano?
Compare medical oncologists in the Plano area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
75
Per 100K population
6.7
County median income
$117,588
Nearest hospital
MEDICAL CITY PLANO
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Connor is a mixed practice specialist, with above-average Medicare volume (top 17% in TX), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Connor experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Connor performed 23,400 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Connor receive payments from pharmaceutical companies?
Yes. Dr. Connor received a total of $1,694 from 24 companies across 47 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Connor's costs compare to other medical oncologists in Plano?
Dr. Connor's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Connor) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →